EX-FILING FEES
Calculation of Filing Fee Tables
Form
S-1
(Form Type)
Titan Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1) | Fee Rate | Amount
of Registration Fee(2) | ||||||||||||||||
Fees to Be Paid | Equity | Shares of common stock, $0.001 par value per share | 457 | (c) | 5,953,834 | (1) | $ | 1.23 | $ | 7,323,216 | 0.0000927 | $ | 678.86 | ||||||||||
Fees to Be Paid | Equity | Shares of common stock, $0.001 par value per share | 457 | (c) | 51,021 | $ | 1.23 | $ | 62,756 | 0.0000927 | $ | 5.82 | |||||||||||
Total Offering Amounts | $ | 7,385,972 | $ | 684.68 | |||||||||||||||||||
Total Fees Previously Paid | 684.68 | ||||||||||||||||||||||
Total Fee Offsets | - | ||||||||||||||||||||||
Net Fee Due | $ | - |
(1) | Represents shares issuable upon exercise of outstanding warrants. Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(2) | Estimated in accordance with Rule 457(c) and (g) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $1.23 per share, which is the average of the high and low prices of the Registrant’s common stock, as reported on the Nasdaq Capital Market, on February 7, 2022. |